Covered recipient · General Payments record
GERMAME H AJEBO
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2023
$4,891.59
- Reported across 261 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,030.12 | 53 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $139.22 | 7 |
| Janssen Biotech, Inc. | $84.26 | 5 |
| Merck Sharp & Dohme Corporation | $79.75 | 4 |
| Celgene Corporation | $75.51 | 4 |
| SEAGEN INC. | $70.32 | 4 |
| Daiichi Sankyo Inc. | $52.09 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $50.04 | 2 |
| Amgen Inc. | $49.74 | 3 |
| PFIZER INC. | $42.06 | 2 |
| Gilead Sciences, Inc. | $40.97 | 2 |
| ACCORD HEALTHCARE, INC. | $33.49 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.89 | 1 |
| Kite Pharma, Inc. | $29.65 | 2 |
| Incyte Corporation | $22.72 | 1 |
| Exelixis Inc. | $22.41 | 1 |
| Karyopharm Therapeutics Inc. | $22.40 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $22.14 | 1 |
| Astellas Pharma US Inc | $21.72 | 1 |
| Pharmacyclics LLC, An AbbVie Company | $21.72 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.17 | 1 |
| TAIHO ONCOLOGY, INC. | $20.00 | 1 |
| Acerta Pharma LLC | $19.46 | 1 |
| Ipsen Biopharmaceuticals, Inc | $15.30 | 1 |
| Coherus Biosciences Inc. | $14.74 | 1 |
| Regeneron Healthcare Solutions, Inc. | $14.24 | 1 |
| MorphoSys, US Inc. | $14.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (53)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.